Biocon inaugurates integrated R&D centre in Bangalore

06 Apr 2012 Evaluate

Biocon, Asia's Premier Biotechnology Company has inaugurated its state of the art integrated Research & Development (R&D) centre in Bangalore. Biocon Research Center (BRC), spread across 200,000 square feet, is aimed at pursuing world class research on biologics that will address unmet medical needs.

As a biotechnology research centre with multi-disciplinary capabilities in Molecular Biology, Biologics Process Sciences, Formulation Research and Preclinical & Clinical Development, BRC is a first- of- its kind facility in South-East Asia.  The centre is also equipped with cutting edge instrumentation for extensive molecular and functional characterization of Biologics.

A team of over 300 scientists based at BRC housed in Biocon Park, will be engaged in cutting edge Biologics research.  The company aims to attract outstanding scientists from the best institutes around the world and engage with international thought leaders as well as participate in technical programs as an effective way to enable innovation through knowledge sharing.

An independent quality group at BRC will ensure compliance to Good Laboratory Practices and International regulatory guidelines for developing ‘best in class’ biologics and biosimilars.

Biocon Share Price

392.80 4.55 (1.17%)
05-Dec-2025 15:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.00
Dr. Reddys Lab 1276.55
Cipla 1520.55
Zydus Lifesciences 933.10
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×